electroCore (ECOR) announced the publication of a peer reviewed paper titled “Non-Invasive Transcutaneous Vagal Nerve Stimulation Enhances Mood, Task Performance, and Learning in a High-Stress Military Training Environment” which will be presented at the Applied Human Factors and Ergonomics Conference on December 8, 2025. The paper presents results from the latest controlled study involving the Company’s proprietary TAC-STIM non-invasive transcutaneous vagal nerve stimulation, tVNS, device, which confirm the ability of the TAC-STIM device to enhance operational performance, resilience, and learning/skill acquisition in high-stress training environments. These findings, the first of their kind conducted in an active-duty operational setting, further position TAC-STIM and related, tVNS/nVNS, devices as transformative solutions with compelling potential for military training and deployment, law enforcement organizations, as well as elite athletes and consumers interested in improved cognitive performance and mood.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ECOR:
- Electrocore’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
- ElectroCore’s Earnings Call: Growth Amid Challenges
- ElectroCore Reports Increased Sales Amidst Continued Losses
- electroCore raises FY25 revenue outlook to $31.5M-$32.5M from $30M
- electroCore reports Q3 EPS (40c), consensus (40c)
